Reuters - A new vaccine to protect women and girls from a sexually transmitted virus that causes cervical cancer comes under scrutiny on Thursday when a U.S. advisory panel considers whether to back approval.

Reuters - Merck & Co. Inc. has provided new data to U.S. regulators showing that all patients who took the arthritis medicine Vioxx were at increased risk of heart attacks, strokes and other complications, National Public Radio reported on Wednesday.

AP - A vaccine that blocks infection by the four virus types that cause most cervical cancers and genital warts appears safe and effective, but may actually increase the chance of disease in some patients, according to Food and Drug Administration documents released Wednesday.

AP - Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found.

AP - Merck & Co., looking for a boost to fight off its Vioxx-related losses, could get it from the first big advance against cervical cancer in a half-century.

AP - Merck & Co., looking for a boost to fight off its Vioxx-related losses, could get it from the first big advance against cervical cancer in a half-century.

AP - Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found.

Reuters - A leading cardiologist on Friday disputed Merck & Co's interpretation on the safety of patients once they stop taking Vioxx, saying they remained at high risk of heart attacks or strokes for some time afterward.

AP - Vioxx users in the study that led to the painkiller being pulled from the market weren't at increased risk of heart attack or stroke in the year after stopping the drug, Merck & Co. said Thursday.

AP - Vioxx users in the study that led to the painkiller being pulled from the market weren't at increased risk of heart attack or stroke in the year after stopping the drug, Merck & Co. said Thursday.

Merck & Co., the giant research-based pharmaceutical company, announced their plans on Tuesday to acquire GlycoFi, Inc., a New Hampshire privately-owned biotechnology company that specializes in yeast glycoengineering and...

AP - An attorney for Vioxx users said on Wednesday said that a new study which suggests the pain killer may cause problems with short-term use may lead to more lawsuits against the pain reliever's maker, Merck & Co.

Shaveta Bansal - AHN Contributor New York, NY (AHN) – A Canadian study, which suggests that Merck’s disputed arthritis painkiller, Vioxx, increases heart attack risk in first few weeks of use, may pose problems for the pharmaceutical giant. The study, reported in the Canadian...

Reuters - An experimental vaccine from Merck & Co Inc designed to protect women against a virus that causes cervical cancer has proved effective for up to five years, researchers said on Wednesday.

AP - A state jury found Merck & Co. liable Friday for the death of a 71-year-old man who had a fatal heart attack within a month of taking its since-withdrawn painkiller Vioxx and ordered the company to pay $32 million. Merck said it would appeal.

Merck will appeal against a verdict that it must pay $32m to a man who had a heart attack after taking Vioxx.

Reuters - A Texas jury on Friday found that the withdrawn painkiller Vioxx caused the death of 71-year-old Leonel Garza and awarded a total of $32 million in damages to his family.

Julie Farby - AHN Staff Writer Rio Grande City, TX (AHN)—After deliberating for more than eight hours over two days, a South Texas jury found Merck & Co. liable for the death of a 71-year-old man who had a fatal heart attack within a month of taking the painkiller Vioxx. The jury...

AP - A state jury found Merck & Co. liable Friday for the death of a 71-year-old man who had a fatal heart attack within a month of taking its painkiller Vioxx and ordered the company to pay $32 million. Merck said it would appeal.

Reuters - Stellar sales of their shared cholesterol drugs spurred Schering-Plough Corp. and Merck & Co. to better-than-expected quarterly results on Thursday, but investors were disappointed by Eli Lilly and Co. as sales of its biggest product continued to slide.